Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: a report of three cases

Multicentric Castleman's disease (MCD) is an inflammatory lymphoproliferative disorder characterized by polyclonal hypergammopathy and dysregulated overproduction of interleukin-6 (IL-6). A variety of renal involvements infrequently arise in patients with MCD. However, there is no established t...

Descripción completa

Detalles Bibliográficos
Autores principales: Komaba, Hirotaka, Nakazawa, Takashi, Yamaguchi, Yutaka, Kumagai, Shunichi, Fukagawa, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477882/
https://www.ncbi.nlm.nih.gov/pubmed/28656995
http://dx.doi.org/10.1093/ndtplus/sfn157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477882/
https://www.ncbi.nlm.nih.gov/pubmed/28656995
http://dx.doi.org/10.1093/ndtplus/sfn157

Ejemplares similares